991
Published in Critical Care Medicine • Dec 1, 2012
NobleIDNI3P163W951R943S219
Authors:,
André C. Kalil
Diana F. Florescu
Abstract
Introduction: Despite same sponsor, same treatment with recombinant human activated protein C, and same placebo-controlled study design, the negative results from PROWESS-SHOCK trial contradicted the positive results, i.e. survival benefit, observed with the original PROWESS trial. Hypothesis: We hy...
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!